<DOC>
	<DOCNO>NCT02178787</DOCNO>
	<brief_summary>Cerebral autoregulation ( CA ) complex mechanism serve essential vital purpose control cerebral blood flow metabolism . A stable optimal brain blood flow imperative normal brain function . Diabetes Mellitus ( DM ) associate microvascular disease alters CA also autonomic failure may lead orthostatic hypotension ( OH ) . These condition may lead decreased brain blood flow upright position . This observational study compare two technology evaluate brain blood flow stand maneuver people without type 2 diabetes . These technology transcranial Doppler UTLight technology ( CerOx ) . This study determine safety feasibility CerOx technology continuous monitor cerebral blood flow .</brief_summary>
	<brief_title>UTLight-transcranial Doppler Assessment Regional Cerebral Autoregulation</brief_title>
	<detailed_description>Cerebral autoregulation ( CA ) complex mechanism serve essential vital purpose control cerebral blood flow metabolism . A stable optimal brain blood flow imperative normal brain function ; therefore normal function CA crucial brain health . Diabetes mellitus ( DM ) associate microvascular disease abnormal autoregulation , increase risk stroke death . Failure CA serious consequence across lifespan , term prevalence adverse outcome related fail CA prominent elderly diabetes . Older diabetic adult often suffer hypotension faint upon standing-up may abnormal CA . With abnormal CA , cerebral perfusion tissue oxygenation decline upon stand . Abnormalities perfusion regulation old people , particularly diabetes may accelerate progression brain atrophy result cognitive decline , vascular dementia Alzheimer 's disease . UTLight technology ( CerOx ) , provide new tool evaluation regional blood flow oxygenation cortical microvasculature , lack clinical medicine patient care . UTLight may become novel tool would provide easy reliable assessment regional perfusion CA specific cortical area health disease widely implement outpatient clinic . This pilot , observational feasibility study compare blood flow measurement use UTLight TCD . Aim 1 : To assess safety feasibility UTLight evaluation regional cerebral blood flow regulation anterior circulation ( ( ACA ) and/or middle cerebral artery ( MCA ) territory ) 20 non-diabetic adult &gt; 50 yr old 40 age-matched adult type 2 diabetes . Aim 2 : To compare profile UTLight blood flow ( UT_BF ) , regional oximetry ( UT_Ox ) TCD-blood flow velocity ( TCD_BFV ) response : 1 ) blood pressure change induce postural change supine head-up tilt , sit standing-up ; 2 ) vasodilatation vasoconstriction response induce hypercapnia hypocapnia . The investigator hypothesize : 1 . UT_BF accurately track TCD_BFV responses anterior circulation ( ACA and/or MCA territory ) blood pressure change , hypercapnia hypocapnia challenge healthy old people . 2 . UT_BF may sensitive detect abnormality regional perfusion diabetic adult compare healthy control compare TCD_BFV . ( UT_Ox ) may provide new indicator identify old diabetic adult brain tissue hypoxia orthostatic challenge may great risk brain damage cognitive decline derive change tissue oxygenation upon stand routinely evaluate TCD . Outcomes : Primary outcome sensitivity specificity UT_BF TCD_BFV blood pressure CO2 challenge , define percent change UT_BF TCD_BFV response hypercapnia hypocapnia challenge . Secondary outcome difference cerebral blood flow measure UT_BF , TCD_BFV healthy old diabetic subject postural change . Third outcomes difference UT_Ox healthy old diabetic subject .</detailed_description>
	<criteria>Diabetes group : This group consist 40 men woman age 5085 year diagnose type 2 DM treat oral agent and/or combination insulin least one year , either normotensive [ BP &lt; 135/85 mm Hg medical history hypertension ) hypertensive [ BP &gt; 130/85 mm Hg and/or treat hypertension ] . Control group : This group nondiabetic ( normal fast blood glucose HbA1c &lt; 6.5 % ) . This group consist 20 men woman match diabetes group age ±5 year , subject normotensive [ BP &lt; 130/85 mm Hg medical history hypertension ] hypertensive [ BP &gt; 130/85 mm Hg and/or treat hypertension ] . Persons one follow condition exclude : 1. type I diabetes ; 2. unstable acute medical condition ; 3. myocardial infarction major surgery within 6 month ; 4. history major stroke ; 5. dementia ( history ) inability follow detail protocol MMSE &lt; 20 ; 6. carotid stenosis &gt; 80 % medical history , Doppler ultrasound , MR angiography ; 7. hemodynamically significant valvular disease ; 8. clinically significant arrhythmia ; 9. liver renal failure transplant ; 10. severe hypertension [ systolic BP &gt; 200 and/or diastolic BP &gt; 110 mm Hg subject take ≥3 antihypertensive medication ] ; 11. seizure disorder ; 12. malignant tumor ; 13. current recreational drug alcohol abuse ; 14. active smoking ; 15. morbid obesity ( BMI &gt; 40 ) . 16 . Women group require postmenopausal . 17 . TCD exclusion criterion poor insonation window TCD signal ; 18 . UT_Light exclusion poor signal .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>cerebral blood flow</keyword>
	<keyword>near infrared spectroscopy</keyword>
	<keyword>transcranial Doppler</keyword>
	<keyword>diabetes mellitus</keyword>
	<keyword>cerebral autoregulation</keyword>
</DOC>